Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses.

Aus Alzaid,Patricia Ladrón de Guevara,Maud Beillat,Valérie Lehner Martin,Petar Atanasov

Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses.

2020

Aus Alzaid
Patricia Ladrón de Guevara
Maud Beillat
Valérie Lehner Martin
Petar Atanasov

To estimate the clinical and economic burden of type 2 diabetes (T2D) in established (EST) and emerging markets (EMG). Three systematic literature reviews were conducted in MEDLINE and Embase to ca...

Keywords:

Intensive care medicine
Emerging markets
MEDLINE
cost of illness
Type 2 diabetes
Medicine
Systematic review
burden of disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

184

References

Citations